We use cookies to improve your experience of our website. Privacy Policy

Skip to main content

Dr Silvia Oggero

Silvia OggeroPhD, personal animal licence, certified phlebotomist

Post Doctoral Research Assistant

Biochemical Pharmacology
William Harvey Research Institute
+44 (0)20 7882 5652

ORCiD LinkedIn



interest and expertise in all in vitro models which wil mimick inflammation and are crucial in the resolution process in various chronic diseases.


Publications of specific relevance to Predictive in vitro Models


Allen BL, Montague-Cardoso K, Simeoli R, Colas RA, Oggero S, Vilar B, McNaughton PA, Dalli J, Perretti M, Sher E and Malcangio M (2020). Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritis. Pain  vol. 161, (9) 2155-2166. 10.1097/j.pain.0000000000001908
(2020). Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cells. Brain, Behavior, and Immunity  10.1016/j.bbi.2020.02.015


Oggero S, Austin-Williams S and Norling LV (2019). The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. Frontiers Media  Frontiers in Pharmacology  vol. 10, 10.3389/fphar.2019.01479


Lashin HMS, Nadkarni S, Oggero S, Jones HR, Knight JC, Hinds CJ and Perretti M (2018). Microvesicle Subsets in Sepsis Due to Community Acquired Pneumonia Compared to Faecal Peritonitis. Shock  vol. 49, (4) 393-401. 10.1097/SHK.0000000000000989


Martin L, Horst K, Chiazza F, Oggero S, Collino M, Brandenburg K, Hildebrand F, Marx G, Thiemermann C and Schuerholz T (2016). The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis. Scientific Reports  vol. 6, 10.1038/srep37277